Arvinas Inc
(NAS:ARVN)
$
34.86
-0.37 (-1.05%)
Market Cap: 2.39 Bil
Enterprise Value: 1.24 Bil
PE Ratio: 0
PB Ratio: 3.90
GF Score: 65/100 Arvinas Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021 / 02:30PM GMT
Release Date Price:
$82.78
(+5.33%)
Terence C. Flynn
Goldman Sachs Group, Inc., Research Division - MD
Great. Good morning, everybody. Thanks for joining us. I'm Terence Flynn, the U.S. biopharma analyst at Goldman Sachs. Today, at our virtual healthcare conference, we're very pleased to be hosting Arvinas. Today, from the company, we have Sean Cassidy, Chief Financial Officer; and Ron Peck, Chief Medical Officer. Thanks so much, both for taking time out of your busy day to join us. We really appreciate it.
Ronald A. Peck
Arvinas, Inc. - Chief Medical Officer
Thank you.
Sean A. Cassidy
Arvinas, Inc. - CFO & Treasurer
Yes. Thanks, Terence, and we also want to thank you and Goldman Sachs for having Arvinas at the 42nd Annual Healthcare Conference. Hopefully, in person...
Terence C. Flynn
Goldman Sachs Group, Inc., Research Division - MD
Looking forward to it -- yes, looking forward to in-person next year.
Sean A. Cassidy
Arvinas, Inc. - CFO & Treasurer
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot